Femasys, Inc. (FEMY)
2.98
+0.02
(+0.68%)
USD |
NASDAQ |
Aug 24, 16:00
2.96
-0.02
(-0.67%)
After-Hours: 05:14
Femasys Gross Profit Margin (Quarterly) : -2.41% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.41% |
| March 31, 2026 | 15.49% |
| December 31, 2025 | 37.23% |
| September 30, 2025 | 30.78% |
| June 30, 2025 | 8.84% |
| March 31, 2025 | 2.02% |
| December 31, 2024 | 29.38% |
| September 30, 2024 | 26.74% |
| June 30, 2024 | -29.71% |
| March 31, 2024 | -15.23% |
| December 31, 2023 | -50.35% |
| September 30, 2023 | -37.97% |
| June 30, 2023 | 1.19% |
| Date | Value |
|---|---|
| March 31, 2023 | -6.73% |
| December 31, 2022 | -27.28% |
| September 30, 2022 | -1.12% |
| June 30, 2022 | -8.38% |
| March 31, 2022 | -9.86% |
| December 31, 2021 | -15.93% |
| September 30, 2021 | -26.48% |
| June 30, 2021 | -8.59% |
| March 31, 2021 | -4.55% |
| December 31, 2020 | -31.21% |
| September 30, 2020 | -14.40% |
| June 30, 2020 | -78.98% |
| March 31, 2020 | -35.24% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -264.2% |
| Return on Assets | -77.19% |
| Return on Invested Capital | -114.3% |
| Profit Margin (Quarterly) | -1.35K% |
| Operating Margin (Quarterly) | -1.53K% |
| Return on Net Operating Assets | -130.9% |